Although primarily used for treatment of stress incontinence, pelvic floor
rehabilitation has been reported to have some value in the treatment of det
rusor instability and urgency.
In neurogenic bladder dysfunction due to Multiple Sclerosis, many authors h
ave suggested the possible use of pelvic floor rehabilitation as a treatmen
t modality. Therefore, we designed an open prospective trial to look at the
possible role of pelvic floor rehabilitation in voiding dysfunction due to
MS, concentrating upon the clinical and neurological parameters in relatio
n to the outcome. A new scoring system for pelvic floor dysfunction is intr
oduced.
Thirty female patients were evaluated. In 25, the strength of the pelvic fl
oor was significantly improved after one month (p < 0.001). In all patients
but one the endurance score improved significantly (p < 0.001) as did the
exhaustibility score (p = 0.01). The relaxation score on the other hand did
not show any significant evolution despite intensive training.
Cystometric findings after one month did not significantly differ from the
initial cystometric findings. There was a significant increase in the mean
functional bladder capacity as read from the voiding charts from 173.8 cc /- 53.9 cc to 208.5 cc +/- 57.6 cc (p = 0.005).
Also the mean urinary frequency decreased significantly from 12.7 +/- 3.6 t
o 9.1 +/- 2.6 (p < 0.01) as did the mean number of daily incontinent episod
es from 2.8 +/- 1.3 to 1.5 +/- 1.5 (p < 0.01).
Pelvic floor rehabilitation has a place in the treatment of MS patients wit
h a low Kurtzke score and without pelvic floor spasticity.